Towards the end of the December quarter, Marico initiated significant steps towards improving the ROI of its general trade channel partners while structurally re-igniting growth in the channel. This included a primary stock correction for its channel partners.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale